Local: Los Angeles, CA  (change)

 | 

Join the Topix community today: 

Sign Up

 | 

Sign In

Advertisment
Myriad Genetics

Jun 30, 2008

Myriad Genetics Reports Results of U.S. Phase 3 Trial of Flurizan in Alzheimer's Disease

Myriad Genetics, Inc. today announced results of the Act-Earli-AD trial, an 18-month Phase 3 study of Flurizan in patients with mild Alzheimer's disease.

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Myriad Genetics Discussions
Topic Updated Last By Comments
Breast Cancer Gene: Who Wants To Know? part II May '08 Julia 1
In-home genetic tests represent risk - (from Oct '07) Oct '07 educated reader 2
Cancer's legacy (from Oct '07) Oct '07 Bust Cheney 1